Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 tat protein and basic fibroblast growth factor

Molecular Biology of the Cell

Volumn 12, Issue 10, 2001, Pages 2934-2946

  Toschi, E ^a   Barillari, G ^a   Sgadari, C ^a   Bacigalupo, I ^a   Cereseto, A ^a   Carlei, D ^a   Palladino, C ^a   Zietz, C ^a   Leone, P ^a   Sturzl M ^a   Butto S ^a   Cafaro, A ^a   Monini, P ^a   Ensoli, B ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGENASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL GROWTH; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; EDEMA; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; GUINEA PIG; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR DISEASE;

EID: 0035158524     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.12.10.2934     Document Type: Article

References (61)

1. Angiogenic properties of human immunodeficiency virus type I Tat protein
2. The angiogenesis induced by HIV-1 Tat protein is mediated by the FIK-1/KDR receptor on vascular endothelial cells
3. Interleukin-1 alpha and basic fibroblast growth factor induction of matrix metalloproteinases and their inhibitors in osteosarcoma cells is modulated by the metastasis associate protein CAPL
4. Transactivator gene of human T-lymphotropic virus type III (HTLV-III)
5. Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells
6. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression: Implications for AIDS-Kaposi's sarcoma pathogenesis
7. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi's sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence
8. The basic and the arginine-glycine-aspartic region of the human immunodeficiency virus type-1 Tat protein promote growth and locomotion of Kaposi's sarcoma and endothelial cells by retrieving heparin-bound basic fibroblast growth factor and by engaging the Symbol" § 125β1 and αvβ3 integrins
9. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of bFGF and αvβ3 integrin that are require for Tat activity
10. Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological media
11. Localization of matrix metalloproteinase M.M.P-2 to the surface of invasive cells by interaction with integrin αvβ3
12. The TIMP-2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study
13. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparin sulfate proteoglycans through its basic region
14. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma
15. Pathogenesis of AIDS-related Kaposi's sarcoma
16. Tat protein of HIV-1 stimulates the growth of cells derived from Kaposi's sarcoma lesions of AIDS patients
17. Release, uptake and effects of extracellular human immunodeficiency virus type I Tat protein on cell growth and viral transactivation
18. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma
19. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor
20. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effect
21. Kaposi's sarcoma: A result of the interplay among inflammatory cytokines, angiogenic factors and viral agents
22. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways
23. Interferon-γ induces endothelial cells to proliferate and to invade the extracellular matrix in response to HIV-1 Tat
24. γSymbol § 12-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with HIV-1 Tat protein: An immune response to HHV-8 infection?
25. Cytokines from activated T. cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells
26. Human immunodeficiency virus Tat modulates the FlK-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells
27. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
28. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells
29. Expression of integrin αvβ3 correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo
30. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma
31. A serratial protease causes vascular permeability reaction by activation of the Hageman factor-dependent pathway in guinea pigs
32. The vascular endothelial growth factor proteins: Identification of biologically relevant regions by neutralizing antibodies
33. Quantitative zymography: Detection of picogram quantities of gelatinase
34. Tumor targeting with a selective gelatinase inhibitor
35. HIV-1 Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells
36. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro
37. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface
38. Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells
39. Regulation of membrane-type metalloproteinase-1 expression by growth factors and phorbol 13-myristate 13-acetate
40. HIV-1 Tat induces phosphorylation of p125FAK and is associated with phosphoinositide 3-kinase in PC12 ceils
41. Detection of herpesvirus-like sequences in Kaposi's sarcoma in patients with and those without HIV infection
42. Evaluation of some newer matrix metalloproteinases
43. Inhibition of development of Kaposi's sarcoma-related lesions by a bacterial cell wall complex
44. A 96-kDa gelatinase induced by TNF-α contributes to increased microvascular endothelial permeability
45. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity
46. The role of matrix metalloproteases and their inhibitors in tumor invasion, metastasis and angiogenesis
47. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases
48. The natural history of Kaposi's sarcoma in acquired immunodeficiency syndrome
49. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice
50. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice
51. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma, are induced by inflammatory cytokines and synergize to induce vascular permeability and KS lesion development
52. Role of the αvβ3 integrin in human melanoma cell invasion
53. Basic fibroblast growth factor increases expression of the αvβ3 integrin complex on human microvascular endothelial cells
54. γ-Interferon production in peripheral blood mononuclear cells (PBMC) and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: Correlation with the presence of human herpesvirus-8 in PBMC and lesional macrophages
55. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with and increase in processing of MT1-MMP (MMP-14) to a 45 kDa form
56. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
57. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2
58. Expression of K13/vFLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells
59. Wild-type p53 gene transfer inhibits invasion and reduces Matrix Metalloproteinase-2 levels in p53-mutated human melanoma cells
60. Molecular regulation of cellular invasion-role of gelatinase A and TIMP-2
61. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation